← Eichor
Study identifier: NCT07454499 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

Condition: Cancer  ·  Sponsor: Abramson Cancer Center at Penn Medicine

PhaseNA
Planned participants60
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of the study is to learn more about ways to help patients understand and manage side-effects from hormone therapy. The investigators will use the information from this study to design future studies to better understand how our well our tools work to help patients monitor and manage symptoms from hormone therapy and to stay on their hormone therapy for the recommended period of time.

This description comes directly from the study's public registry record.

Talk to the study team

Kimberley Lee  ·  215-615-1736  ·  kimberley.lee@pennmedicine.upenn.edu

Kelsey Karpink  ·  215-662-3531  ·  kelsey.karpink@pennmedicine.upenn.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Abramson Cancer Center at the University of PennsylvaniaPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07454499